Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 57:534-535, 2008
DOI: 10.2337/db08-0007
© 2008 by the American Diabetes Association
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, C.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Commentary

Interaction Between Exercise and Leptin in the Treatment of Obesity

Christopher Morrison

From the Pennington Biomedical Research Center, Baton Rouge, Louisiana

Address correspondence and reprint requests to Christopher Morrison, Pennington Biomedical Research Center, 6400 Perkins Rd., Baton Rouge, LA 70808. E-mail: morriscd{at}pbrc.edu

Recent data indicate that roughly 32% of the U.S. population is obese and an additional 34% is overweight (1). Considering the physical, psychological, and physiological complications associated with obesity, developing approaches to reduce these numbers is of critical importance. The identification of leptin as a hormonal link between energy stores and the brain inspired a renewed focus on the study of energy balance and contributed to the description of a neuronal network that mediates the metabolic regulation of feeding behavior, reproduction, glucose homeostasis, immune function, bone formation, lipid metabolism, etc. But for all its promise, much of the initial enthusiasm over leptin has waned with the realization that obese individuals respond rather poorly to leptin treatment and manifest a syndrome of leptin resistance. Although leptin may not be the anti-obesity treatment initially hoped for, there may yet be life to the leptin story. Just as progress has been made in defining and overcoming insulin resistance, considerable effort has focused on developing approaches to overcome leptin resistance. In this issue of Diabetes, Shapiro et al. (2) provide evidence that modest exercise synergizes with leptin treatment to markedly reduce body weight in individuals made obese by a high-fat diet, even though neither reduce body weight alone.

The importance of leptin in energy balance is illustrated by the extreme obese phenotype induced by leptin deficiency, and by the dramatic reduction in food intake and body weight that occurs upon treatment of this condition with leptin. While leptin levels are closely matched to body adiposity at steady state, negative energy balance produces a fall in leptin levels that is more rapid than the change in body adiposity. Preventing this fall is sufficient to attenuate many of the physiological events associated with negative energy balance, and it is widely agreed that leptin is a critical signal of weight loss. However, is the opposite also true? That is, does increased leptin serve as a signal of positive energy balance? Though the answer to this question is unclear, there is increasing evidence that enhancing leptin sensitivity produces a lean, obesity-resistant phenotype (36). These observations therefore suggest that leptin may indeed act to prevent weight gain, and that enhancing leptin sensitivity might be beneficial in the fight against obesity.

The work by Shapiro et al. (2) builds upon previous experiments by the Scarpace group. This work demonstrates not only that prolonged leptin overexpression is ineffective at reducing body weight in obese rats, but also that chronic leptin treatment actually worsens diet-induced obesity (2,7). Far from providing a cure, chronic hyperleptinemia might actually contribute to obesity. But why would increased leptin levels make matters worse? First, it is important to note that the effect only occurs in animals on a high-fat diet, as those rats on a low-fat diet exhibited the expected leptin-induced reduction in body weight. Second, it appears that even a modest amount of exercise (in this case, wheel running) is sufficient to fully reverse this process and restore the response to exogenous leptin administration. This is perhaps the most profound observation in the study. Even though wheel running alone had no effect in obese rats, and despite the fact that leptin treatment made matters worse, the combination of the two produced a marked weight loss.

These unique outcomes leave us with a series of questions. Why does leptin treatment reduce body weight in chow-fed rats but paradoxically worsen obesity on a high-fat diet? Why does wheel running reduce weight in animals overexpressing leptin but have no effect in diet-induced obese controls, even though they are also hyperleptinemic and presumably leptin resistant? The authors logically focus on changes in leptin sensitivity as the underlying cause. In a previous study, the Scarpace lab demonstrated that when lean rats were subjected to chronic leptin overexpression, the initial decrease in body weight waned over time in association with a reduction in leptin sensitivity. When these rats were then placed on a high-fat diet, they displayed an enhanced diet-induced hyperphagia and weight gain (7). Together with the current work, these experiments indicate that by inducing leptin resistance, chronic hyperleptinemia attenuates the ability to resist diet-induced obesity.

It is likely that changes in leptin sensitivity may underlie the effects of wheel running as well. Previous experiments show that an acute bout of exercise improves leptin sensitivity (8), and in the current study markers of leptin action (pStat3 and Socs3) are increased in animals receiving the combination of leptin treatment and wheel running. Although phosphorylation of Stat3 is often used as a measure of leptin sensitivity, this is usually done in the context of acute administration. The current experiments measure steady-state levels, and in this scenario it is not clear how closely pStat3 levels correlate with leptin sensitivity. Furthermore, although high-fat diets and chronic leptin overexpression are proposed to induce leptin resistance, neither led to clear alterations in pStat3 and Socs3 levels compared with appropriate control rats in the current study. Thus, although some observations are consistent with a change in leptin sensitivity, the work falls short of providing definitive proof. It is also curious that the effects of wheel running are only manifest in conjunction with exogenous leptin administration. If enhanced leptin sensitivity were the underlying mechanism, it would be expected that wheel running would also reduce body weight in the high fat–fed controls, since these animals are also hyperleptinemic and presumably leptin resistant. As noted by the authors, this outcome suggests there is something unique about exogenous leptin administration.

Developing approaches to resist or treat obesity is of critical importance to the U.S. health care industry. Shapiro et al. (2) highlight a synergistic interaction between leptin treatment and exercise and add to a growing list of experiments which indicate that enhancing leptin sensitivity reduces body weight and prevents diet-induced obesity. Leptin may yet yield an obesity treatment; in the meantime, perhaps I should go for a run.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

See accompanying Original Article, p. 614.


    REFERENCES
 TOP
 REFERENCES
 

  1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555, 2006[Abstract/Free Full Text]
  2. Shapiro A, Matheny M, Zhang Y, Tumer N, Cheng KY, Rogrigues E, Zolotukhin S, Scarpace PJ: Synergy between leptin therapy and a seemingly negligible amount of voluntary wheel running prevents progression of dietary obesity in leptin-resistant rats. Diabetes 57:614–622, 2008[Abstract/Free Full Text]
  3. Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, Kahn BB: Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 12:917–924, 2006[Medline]
  4. Bjornholm M, Munzberg H, Leshan RL, Villanueva EC, Bates SH, Louis GW, Jones JC, Ishida-Takahashi R, Bjorbaek C, Myers MG Jr: Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. J Clin Invest 117:1354–1360, 2007[Medline]
  5. Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjorbaek C, Flier JS: Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 10:734–738, 2004[Medline]
  6. Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, Torisu T, Chien KR, Yasukawa H, Yoshimura A: Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 10:739–743, 2004[Medline]
  7. Scarpace PJ, Matheny M, Tumer N, Cheng KY, Zhang Y: Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signalling capacity in rats. Diabetologia 48:1075–1083, 2005[Medline]
  8. Flores MB, Fernandes MF, Ropelle ER, Faria MC, Ueno M, Velloso LA, Saad MJ, Carvalheira JB: Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats. Diabetes 55:2554–2561, 2006[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article:

Synergy Between Leptin Therapy and a Seemingly Negligible Amount of Voluntary Wheel Running Prevents Progression of Dietary Obesity in Leptin-Resistant Rats
Alexandra Shapiro, Michael Matheny, Yi Zhang, Nihal Tümer, Kit-Yan Cheng, Enda Rogrigues, Sergei Zolotukhin, and Philip J. Scarpace
Diabetes 2008 57: 614-622. [Abstract] [Full Text] [PDF]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, C.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum